Group 1 - The company, Jincheng Pharmaceutical, is collaborating with China Pharmaceutical University on the long-acting progesterone injection project [1] - Progesterone, also known as luteal hormone, is a natural hormone secreted by the ovarian corpus luteum [1]

Core Viewpoint - The company is in negotiations for exclusive commercialization rights of ExEm Foam in China, which is used for evaluating tubal patency in women with infertility [1] Group 1 - The company confirmed ongoing negotiations with Giskit Pharma B.V. regarding ExEm Foam's exclusive commercialization rights in China, but there are no recent updates on the progress [1] - The company is collaborating with China Pharmaceutical University to develop long-acting formulations for drugs related to reproductive health and women's diseases, specifically focusing on a progesterone long-acting injection project [1] - The company will announce any necessary disclosures regarding these matters in a timely manner [1]